Akihiko Suto

1.3k citations
63 papers · 945 indexed · h-index 15
Topics
Breast Cancer Treatment Studies (20 papers)HER2/EGFR in Cancer Research (12 papers)Breast Lesions and Carcinomas (11 papers)

In The Last Decade

Akihiko Suto

58 papers receiving 889 citations

Peers

Akihiko Suto
Comparison fields: 5 of 80
  • Oncology 503
  • Molecular Biology 285
  • Genetics 260
  • Cancer Research 190
  • Pulmonary and Respiratory Medicine 188
Replace Ermelinda De Maio with:
Ermelinda De Maio Italy
Biagio Agostara Italy
E.L. Levine United Kingdom
Claus Lattrich Germany
B.M.J. Cantwell United Kingdom
Tomohide Tamura Japan
Yu-Chien Chou United States
Paul V. Plourde United States
Virginia K. Pierce United States
Gregory H. Ripple United States
Akihiko Suto relative to Ermelinda De Maio Italy Ermelinda De Maio's profile →
Citations per field
00.5×5.9×
Ermelinda De Maio · 1×
Citations per year

Countries citing papers authored by Akihiko Suto

Since Specialization
Citations

This map shows the geographic impact of Akihiko Suto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Suto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Suto more than expected).

Fields of papers citing papers by Akihiko Suto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Suto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Suto. The network helps show where Akihiko Suto may publish in the future.

Co-authorship network of co-authors of Akihiko Suto

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Suto. A scholar is included among the top collaborators of Akihiko Suto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Suto. Akihiko Suto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 4
5 5
6 18
7 2
8 9
9 0
10 33
11 1
12 4
13 5
14 23
15 31
16 53
17 12
18 1
19 31
20 54

About Akihiko Suto

Akihiko Suto is a scholar working on Cancer Research, Oncology and Toxicology, having authored 63 papers that have together received 945 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (12 papers) and Breast Lesions and Carcinomas (11 papers). The work is most often cited by research in Oncology (503 citations), Cancer Research (190 citations) and Genetics (260 citations). Akihiko Suto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Nitin Telang, H. Leon Bradlow, George Y. Wong, Michael P. Osborne, Tetsuro Kubota, Kyuya Ishibiki, Shin Takayama, Sho Shiino, Osahiko Abe and Masaki Kitajima. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026